Outcomes of Preserving the Hypertrophic Arachnoid Membrane in the Brain-meningioma Interface: Long-term Follow-up.


Journal

Neurologia medico-chirurgica
ISSN: 1349-8029
Titre abrégé: Neurol Med Chir (Tokyo)
Pays: Japan
ID NLM: 0400775

Informations de publication

Date de publication:
15 Feb 2022
Historique:
pubmed: 2 11 2021
medline: 19 2 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

Abnormal hypertrophic arachnoid membranes are often observed in the brain-meningioma interface during microsurgery. They contain fibrosis and tumor cell clusters; however, preservation of the membranes does not always cause recurrence from the brain surface, and the optimal treatments in the interface remain unclear. We investigated the incidence of recurrence on the brain surface following extra-arachnoid dissection with an approach emphasizing preservation of the arachnoid membranes in meningiomas of World Health Organization (WHO) Grade I. The features of dissection cleavages in the interface were prospectively recorded at surgery. The patients were followed up with MR imaging regularly. In total, 111 patients were included. The median follow-up time was 97.0 (interquartile range [IQR] 70.0-124.0) months. The cleavages in the interface were classified into three subgroups: the Extra-H group (n = 56) with extra-arachnoid resection and preservation of hypertrophic arachnoid membranes, the Extra-N group (n = 39) with extra-arachnoid resection having normal membranes, and the Subpial resection group (n = 16). Tumors recurred in 13 (11.7%) patients at both the brain and dura mater (n = 1) or at the dura mater alone (n = 12). The median recurrence-free survival (RFS) of all recurrences was significantly related to the Simpson grades (P <0.01). For brain surface recurrence, the median RFS was not related to the subgroups. The Karnofsky Performance Scores (KPSs) significantly improved in the patients except for the Subpial group at 3 months after surgery. This study revealed that hypertrophic arachnoid membranes preserved on the brain surface rarely caused recurrence from the brain in WHO Grade I meningiomas after a long-term follow-up.

Identifiants

pubmed: 34719581
doi: 10.2176/nmc.oa.2021-0209
pmc: PMC8841235
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-88

Références

J Neurosurg. 2020 Dec 4;:1-10
pubmed: 33276341
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39
pubmed: 13406590
J Neurosurg. 2010 Nov;113(5):1029-35
pubmed: 20380529
J Neurosurg. 2012 Dec;117(6):999-1006
pubmed: 23061394
Neurosurgery. 2008 Sep;63(3):427-33; discussion 433-4
pubmed: 18812953
Cancer. 2000 Sep 1;89(5):1102-10
pubmed: 10964341
Neurosurgery. 2007 Nov;61(5):1048-59; discussion 1060-1
pubmed: 18091281
Surg Neurol. 2001 Oct;56(4):228-35
pubmed: 11738666
J Neurosurg. 2019 Jun 14;:1-12
pubmed: 31200378
Brain Tumor Pathol. 2005;22(2):53-7
pubmed: 18095106
J Neurosurg. 2011 Sep;115(3):491-8
pubmed: 21663413
World Neurosurg. 2017 Apr;100:601-606
pubmed: 28137543
J Neurosurg. 2016 Sep;125(3):551-60
pubmed: 26824369
Brain Tumor Pathol. 2021 Apr;38(2):81-95
pubmed: 33403457
Front Oncol. 2020 Oct 05;10:585313
pubmed: 33123487
Cancer. 1999 May 1;85(9):2046-56
pubmed: 10223247
J Neurosurg. 2019 Feb 15;132(2):380-387
pubmed: 30771770
Acta Neurochir (Wien). 2019 Feb;161(2):333-341
pubmed: 30675656
J Neurosurg. 2019 May 10;132(6):1675-1682
pubmed: 31075775
Neurol Med Chir (Tokyo). 2020 Mar 15;60(3):109-120
pubmed: 32009127
Surg Neurol. 2004 Feb;61(2):149-55; discussion 155-6
pubmed: 14751627
Neurosurgery. 1998 Mar;42(3):476-80
pubmed: 9526980
J Neurooncol. 2017 Jul;133(3):641-651
pubmed: 28527009

Auteurs

Yoko Nakasu (Y)

Division of Neurosurgery, Shizuoka Cancer Center.
Department of Neurosurgery, Shiga University of Medical Science.

Koichi Mitsuya (K)

Division of Neurosurgery, Shizuoka Cancer Center.

Satoshi Nakasu (S)

Department of Neurooncology, Kusatsu General Hospital.

Shoichi Deguchi (S)

Division of Neurosurgery, Shizuoka Cancer Center.

Nakamasa Hayashi (N)

Division of Neurosurgery, Shizuoka Cancer Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH